Manufacturing distinct xanthine derivatives is an area of competence for Aarti Pharmalabs Limited (APL). These include, to name a few, caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline. The beverage, nutraceutical, and pharmaceutical industries all employ these derivatives. Two manufacturing facilities have been designated to the production of xanthine derivatives and have been awarded star certifications for manufacturing and testing, including Star Kosher, Hazard Analysis Critical Control Point (HACCP), Sedex SMETA-4PillarP, FSSC-22000 (GFSI), and GMP. These top-notch production plants have a huge capacity for our star commodity, caffeine (3600 MT capacity per annum).
For Xanthine Derivatives Enquiries mail us on:
Our range of Xanthine Derivatives products
|DMAU (6-Amino-1,3-Dimethyl Uracil)||6642-31-5||Inhouse||Available|
|Etofylline||519-37-9||IP"85 & BP"2012||Available|